CGON · NASDAQ
CG Oncology (CGON) Stock Price & Fundamentals
CG Oncology (CGON) closed at $419.66 on Oct 9, 2026, up 0.48% from the previous close of $417.66.
Share price, past year
1Y +13.02%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $419.66 |
| Sep 30, 2026 | $423.30 |
| Aug 31, 2026 | $423.41 |
| Jul 31, 2026 | $419.39 |
| Jun 30, 2026 | $432.36 |
| May 29, 2026 | $404.12 |
| Apr 30, 2026 | $400.80 |
| Mar 31, 2026 | $396.30 |
| Feb 27, 2026 | $389.00 |
| Jan 30, 2026 | $386.76 |
| Dec 31, 2025 | $372.63 |
| Nov 28, 2025 | $386.73 |
| Oct 31, 2025 | $384.69 |
Key statistics
- Market cap
- $37.06B
- P/E (TTM)
- —
- EPS (TTM)
- −$2.70
- Revenue (TTM)
- $6.23M
- Net income (TTM)
- −$224.38M
- Shares outstanding
- 88.3M
- Dividend yield
- —
- 52-week range
- $367.68 – $446.07
CG Oncology's market cap is $37.06B, based on a share price of $419.66 and 88.3M shares outstanding as of Jun 30, 2026.
Financials
CG Oncology reported revenue of $4.04M for fiscal 2025, up 254.70% from fiscal 2024.
CG Oncology reported a net loss of $161.00M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $4.04M | +254.7% | −$161.00M | −3,985.0% | −$2.08 | −$132.48M |
| FY2024ended Dec 31, 2024 | $1.14M | +458.3% | −$88.04M | −7,729.5% | −$1.41 | −$78.95M |
| FY2023ended Dec 31, 2023 | $204.00K | — | −$48.61M | −23,827.0% | −$15.65 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $1.16M | −$79.06M | −$0.90 |
| Q1 FY2026ended Mar 31, 2026 | $1.08M | −$60.20M | −$0.71 |
| Q4 FY2025ended Dec 31, 2025 | $2.32M | −$41.31M | −$0.52 |
| Q3 FY2025ended Sep 30, 2025 | $1.67M | −$43.81M | −$0.57 |
| Q2 FY2025ended Jun 30, 2025 | $0.00 | −$41.43M | −$0.54 |
| Q1 FY2025ended Mar 31, 2025 | $52.00K | −$34.45M | −$0.45 |
| Q4 FY2024ended Dec 31, 2024 | $456.00K | −$31.80M | −$0.47 |
| Q3 FY2024ended Sep 30, 2024 | $43.00K | −$20.41M | −$0.30 |
Company profile
- Name
- CG Oncology, Inc.
- Ticker
- CGON
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 3000 Pegasus Park Drive, Suite 1640, Dallas, TX 75247
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001991792
Recent SEC filings
- Aug 6, 2026
- Aug 6, 2026
- Jun 8, 2026
- May 26, 2026
- May 8, 2026
- May 8, 2026
- Apr 13, 2026
- Feb 27, 2026
Frequently asked questions
What is CG Oncology's stock price?
CG Oncology (CGON) closed at $419.66 on Oct 9, 2026, up 0.48% from the previous close of $417.66.
What is CG Oncology's market cap?
CG Oncology's market cap is $37.06B, based on a share price of $419.66 and 88.3M shares outstanding as of Jun 30, 2026.
How much revenue does CG Oncology make?
CG Oncology reported revenue of $4.04M for fiscal 2025, up 254.70% from fiscal 2024.
Does CG Oncology pay a dividend?
CG Oncology's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from CG Oncology, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures